Regeneron Pharmaceuticals, Inc.

General ticker "REGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $95.7B (TTM average)

Regeneron Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -2.4%.

Estimated limits based on current volatility of 2.3%: low 541.45$, high 566.92$

Factors to consider:

  • Earnings expected soon, date: 2025-04-29 bmo
  • Company included in S&P500 list
  • Company included in NASDAQ-100 index
  • Company pays dividends (irregularly): last record date 2025-02-20, amount 0.88$ (Y0.16%)
  • US accounted for 8.5% of revenue in the fiscal year ended 2024-12-31
  • Current price 12.6% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [644.54$, 952.52$]
  • 2025-12-31 to 2026-12-31 estimated range: [698.53$, 1012.41$]

Financial Metrics affecting the REGN estimates:

  • Positive: Non-GAAP EPS, $ of 45.64 > 2.19
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: Interest expense per share, $ of 0.51 <= 0.67
  • Positive: Operating profit margin, % of 28.21 > 18.46
  • Positive: Return on assets ratio (scaled to [-100,100]) of 10.46 > 6.86
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 77.74 > 63.75
  • Positive: Inventory ratio change, % of 0.89 <= 1.05

Similar symbols

Short-term REGN quotes

2025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-17550600650700750
Price $

Long-term REGN plot with estimates

600700800900100011001200Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 20270510
REGNS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $12,262.80MM $13,119.30MM $14,148.60MM
Operating Expenses $7,523.90MM $9,072.20MM $10,157.90MM
Operating Income $4,738.90MM $4,047.10MM $3,990.70MM
Non-Operating Income $119.90MM $152.20MM $789.20MM
Interest Expense $59.40MM $73.00MM $55.20MM
R&D Expense $3,847.60MM $4,625.10MM $5,233.00MM
Income(Loss) $4,858.80MM $4,199.30MM $4,779.90MM
Taxes $520.40MM $245.70MM $367.30MM
Profit(Loss)* $4,338.40MM $3,953.60MM $4,412.60MM
Stockholders Equity $22,664.00MM $25,973.10MM $29,353.60MM
Inventory $2,401.90MM $2,580.50MM $3,087.30MM
Assets $29,214.50MM $33,080.20MM $37,759.40MM
Operating Cash Flow $5,014.90MM $4,594.00MM $4,420.50MM
Capital expenditure $590.10MM $926.40MM $755.90MM
Investing Cash Flow $-3,784.60MM $-3,185.10MM $-2,468.10MM
Financing Cash Flow $-1,009.00MM $-1,790.10MM $-2,200.50MM
Earnings Per Share** $40.51 $37.05 $40.90

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.